SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001104659-24-130903 from Aesthetic Medical International Holdings Group Ltd (PAIYY)

Aesthetic Medical International Holdings Group Ltd
Date: Dec. 20, 2024 · CIK: 0001757143 · Accession: 0001104659-24-130903

AI Filing Summary & Sentiment

File numbers found in text: 001-39088

Date
December 31, 2023
Author
/s/ Guanhua Wu
Form
CORRESP
Company
Aesthetic Medical International Holdings Group Ltd

Letter

VIA EDGAR Securities and Exchange Commission Division of Corporation Finance Office of Industrial Applications and Services Re: Aesthetic Medical International Holdings Group Ltd Form 20-F for Fiscal Year Ended December 31, 2023 Filed April 25, 2024 File No. 001-39088

Dear Mr. Danberg and Ms. Sawicki:

Aesthetic Medical International Holdings Group Ltd (the “Company”) confirms receipt of the letter from the staff (the “Staff”) of the Securities and Exchange Commission (the “Commission”) dated November 25, 2024, regarding the Company’s annual report on Form F-20 for the fiscal year ended December 31, 2023 filed on April 25, 2024. The Company is actively preparing a reply letter that proposes edits to be included on the Form 20-F for the fiscal year ended December 31, 2024 in response to the Staff’s comments. To better address the Staff’s comments with the proposed edits and further improve the quality of our disclosure, we respectfully submit to the Staff to request an extension until January 10, 2025 to submit our response to the Staff’s comments.

If you have any further questions or comments, please do not hesitate to contact the Company at (+86) 139-2862-0496 or toby@pengai.com.cn.

Sincerely,
/s/ Guanhua Wu

Show Raw Text
CORRESP
1
filename1.htm

Aesthetic Medical International
Holdings Group Ltd

December 20,
2024

VIA EDGAR

Mr. Conlon Danberg

Ms. Margaret Sawicki

Securities and Exchange Commission

Division of Corporation Finance

Office of Industrial Applications and Services

100 F Street, N.E.

Mail Stop 4631

Washington, DC 20549

    Re:
    Aesthetic Medical International Holdings Group Ltd

    Form 20-F for Fiscal Year Ended December 31, 2023

    Filed April 25, 2024

    File No. 001-39088

Dear
Mr. Danberg and Ms. Sawicki:

Aesthetic
Medical International Holdings Group Ltd (the “Company”) confirms receipt of the letter from the staff (the “Staff”)
of the Securities and Exchange Commission (the “Commission”) dated November 25, 2024, regarding the Company’s
annual report on Form F-20 for the fiscal year ended December 31, 2023 filed on April 25, 2024. The Company is actively
preparing a reply letter that proposes edits to be included on the Form 20-F for the fiscal year ended December 31, 2024 in
response to the Staff’s comments. To better address the Staff’s comments with the proposed edits and further improve the quality
of our disclosure, we respectfully submit to the Staff to request an extension until January 10, 2025 to submit our response to the
Staff’s comments.

If
you have any further questions or comments, please do not hesitate to contact the Company at (+86) 139-2862-0496 or toby@pengai.com.cn.

    Sincerely,

    /s/ Guanhua Wu

    Guanhua Wu

    Chief Financial Officer